FilingReader Intelligence

Alembic Pharma to announce half-year results November 4

October 23, 2025 at 07:09 AM UTCBy FilingReader AI

Alembic Pharmaceuticals Limited is scheduled to hold a board of directors meeting on Tuesday, November 4, 2025. The primary agenda for this meeting is to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2025.

In compliance with the company's code of conduct, the trading window for designated persons and their immediate relatives, which was closed from October 1, 2025, will re-open 48 hours after the declaration of these financial results. The company has formally notified both BSE Limited and the National Stock Exchange of India Ltd. of this upcoming board meeting and the purpose of the deliberation.

The announcement was made on October 23, 2025, by Manisha Saraf, company secretary. The market will be closely watching for the release of these results to gauge the company's performance during the specified periods.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when ALEMBIC PHARMACEUTICALS publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →